Enlivex Therapeutics Ltd. announced an investor webinar scheduled for March 5, 2025, at 11:00 a.m. ET to discuss promising interim results from its Phase I/II Allocetra™ trial for treating moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results